Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status
Ioline D. Henter, Lawrence T. Park, Carlos A. Zarate
CNS Drugs (2021) Vol. 35, Iss. 5, pp. 527-543
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Ketamine treatment for depression: a review
Mani Yavi, Holim Lee, Ioline D. Henter, et al.
Discover Mental Health (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 82
The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de‐risk trial programmes of novel agents
Christoph U. Correll, Marco Solmi, Samuele Cortese, et al.
World Psychiatry (2023) Vol. 22, Iss. 1, pp. 48-74
Open Access | Times Cited: 81
New and emerging approaches to treat psychiatric disorders
Katherine W. Scangos, Matthew W. State, Andrew H. Miller, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 317-333
Closed Access | Times Cited: 70
Ketamine in neuropsychiatric disorders: an update
Jenessa N. Johnston, Bashkim Kadriu, Christoph Kraus, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 23-40
Closed Access | Times Cited: 47
Novel drug developmental strategies for treatment‐resistant depression
Éva Borbély, Mária Simon, Eberhard Fuchs, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 6, pp. 1146-1186
Open Access | Times Cited: 65
Novel rapid-acting glutamatergic modulators: Targeting the synaptic plasticity in depression
Yating Wang, Xiaole Wang, Sitong Feng, et al.
Pharmacological Research (2021) Vol. 171, pp. 105761-105761
Closed Access | Times Cited: 56
Ketamine activates adult-born immature granule neurons to rapidly alleviate depression-like behaviors in mice
Radhika Rawat, Elif Tunc‐Ozcan, Tammy L. McGuire, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 47
GluN2A mediates ketamine-induced rapid antidepressant-like responses
Tonghui Su, Yi Lu, Chaoying Fu, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 10, pp. 1751-1761
Closed Access | Times Cited: 24
Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders
Pratik Chakraborty, Abhijit Dey, Abilash Valsala Gopalakrishnan, et al.
Ageing Research Reviews (2023) Vol. 85, pp. 101838-101838
Closed Access | Times Cited: 23
The importance of the gut microbiome and its signals for a healthy nervous system and the multifaceted mechanisms of neuropsychiatric disorders
Lydia Riehl, Johannes Fürst, Michaela Kress, et al.
Frontiers in Neuroscience (2024) Vol. 17
Open Access | Times Cited: 13
Gut-Brain Axis: Role of Microbiome, Metabolomics, Hormones, and Stress in Mental Health Disorders
Ankita Verma, Sabra S. Inslicht, Aditi Bhargava
Cells (2024) Vol. 13, Iss. 17, pp. 1436-1436
Open Access | Times Cited: 11
The role and mechanism of tryptophan – kynurenine metabolic pathway in depression
Xiaoli Gong, Rui Chang, Ju Zou, et al.
Reviews in the Neurosciences (2022) Vol. 34, Iss. 3, pp. 313-324
Closed Access | Times Cited: 34
Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search
Jordi Bonaventura, Juan L. Gomez, Meghan L. Carlton, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 10, pp. 4144-4156
Open Access | Times Cited: 31
Dextromethorphan/Bupropion: First Approval
Susan J. Keam
CNS Drugs (2022) Vol. 36, Iss. 11, pp. 1229-1238
Closed Access | Times Cited: 31
Glutamatergic receptor and neuroplasticity in depression: Implications for ketamine and rapastinel as the rapid-acting antidepressants
Yating Wang, Ningning Zhang, Lingjie Liu, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 594, pp. 46-56
Closed Access | Times Cited: 30
Nucleus accumbens in the pathogenesis of major depressive disorder: A brief review
Jiang Yajie, Manshu Zou, Yeqing Wang, et al.
Brain Research Bulletin (2023) Vol. 196, pp. 68-75
Open Access | Times Cited: 19
Biomarkers of bipolar disorder based on metabolomics: A systematic review
Jin Chen, Nousayhah Amdanee, Xiaowei Zuo, et al.
Journal of Affective Disorders (2024) Vol. 350, pp. 492-503
Closed Access | Times Cited: 6
Ketamine’s rapid and sustained antidepressant effects are driven by distinct mechanisms
Radhika Rawat, Elif Tunc‐Ozcan, Sara Dunlop, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 6
Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective—a new and evolving approach
Phil Wolfson, Gita Vaid
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 5
NMDA receptors as therapeutic targets for depression treatment: Evidence from clinical to basic research
Shiyun Lv, Kejie Yao, Youyi Zhang, et al.
Neuropharmacology (2022) Vol. 225, pp. 109378-109378
Closed Access | Times Cited: 24
Targeting NMDA Receptors at the Neurovascular Unit: Past and Future Treatments for Central Nervous System Diseases
Célia Seillier, Flavie Lesept, Olivier Toutirais, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10336-10336
Open Access | Times Cited: 23
mGlu2/3 receptor antagonists for depression: overview of underlying mechanisms and clinical development
Shigeyuki Chaki, Mai Watanabe
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1451-1462
Closed Access | Times Cited: 14
Peripheral inflammation triggering central anxiety through the hippocampal glutamate metabolized receptor 1
Jun‐Meng Wang, Yue‐Mei Wang, Yuanbing Zhu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 4
Open Access | Times Cited: 4
Depression clinical trials worldwide: a systematic analysis of the ICTRP and comparison with ClinicalTrials.gov
Eugenia D. Namiot, Diana Smirnovová, Aleksandr V. Sokolov, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
The gut microbiome and the brain
N. A. Rykalo, Lydia Riehl, Michaela Kress
Current Opinion in Supportive and Palliative Care (2024)
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top